Bioterrorism and Drug Preparedness
To help prepare our country for possible bioterrorism attacks, FDA is working with other federal agencies to make sure adequate supplies of medicine and vaccines are available to the American public. This page provides links to the most current information on drug therapy and vaccines, plus advice on purchasing and taking medication.
- Products Approved for Anthrax
- Products Approved for Other Bioterrorism Emergencies
- Products Approved for Radiation and Nuclear Emergencies
- Products Approved for Chemical Emergencies
- Pediatric Medical Countermeasures
FDA Resources
- Counterterrorism and Emerging Threats
- Medical Countermeasures Initiative (MCMi)
- Emergency Preparedness and Response
- Pediatric Medical Countermeasures
- Product Development Under the Animal Rule Guidance for Industry (2015)
- Animal Rule Approvals
- FDA Animal Model Qualification Program
- Pandemic and All-Hazards Preparedness Reauthorization Act of 2013
- Emergency Use Authorization
- Expiration Dating Extension
Additional Resources
- Biodefense and Bioterrorism from MEDLINEplus
- Centers for Disease Control and Prevention: Emergency Preparedness and Response
- CDC Emergency Preparedness and Response
- U.S. Department of Health & Human Services Public Health Emergency
- U.S. Department of Health & Human Services CHEMM: Chemical Hazards Emergency Medical Management
- U.S. Department of Health & Human Services REMM: Radiation Emergency Medical Management
- Ready.gov emergency preparedness guidance from the U.S. Department of Homeland Security